Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT06852950
- Status
- Recruiting
Conditions
- Hyperglycemia
- Type 1 Diabetes Mellitus (T1DM)
- Type 2 Diabetes Mellitus (T2DM)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Libre 3 Plus Continuous Glucose Monitor — DEVICESubjects in this arm will start using the Libre 3 Plus continuous glucose monitor.
- Dexcom G7 Continuous Glucose Monitor — DEVICESubjects in this arm will start using the Dexcom G7 continuous glucose monitor.
Study Details
This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting to the ambulatory setting.
Key Dates
- Start date
- Mar 9, 2025
- Status verified
- Mar 2026
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Libre 3 Plus Continuous Glucose MonitorSubjects in this arm will start using the Libre 3 Plus continuous glucose monitor.
- Experimental: Dexcom G7 Continuous Glucose MonitorSubjects in this arm will start using the Dexcom G7 continuous glucose monitor.
Primary Outcome Measure
Questionnaire responses regarding patient satisfaction and opinion regarding use of continuous glucose monitoring system [ Time Frame: From enrollment until follow-up telephone visit 2-3 weeks after discharge ]
Central Contacts
- Angel Morvant, MD615-343-8332
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Angel Morvant, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Nashville, TN
By research site
Related Studies
- Low-Dose Pioglitazone in Patients With NASH (AIM 2)PHASE2 · Recruiting · University of Florida · Gainesville, Florida
- Human Immunodeficiency Virus (HIV) Food InsecuritiesRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Diabetes Clinical Decision SupportRecruiting · Milton S. Hershey Medical Center · Hershey, Pennsylvania
- Effect of Zinc on Glucose HomeostasisPHASE4 · Recruiting · University of Maryland, Baltimore · Lancaster, Pennsylvania